Akpinar, S.; Dogu, M.H.; Celik, S.; Ekinci, O.; Hindilerden, I.Y.; Dal, M.S.; Davulcu, E.A.; Tekinalp, A.; Hindilerden, F.; Ozcan, B.G.; Hacibekiroglu, T.; Erkurt, M.A.; Bagci, M.; Namdaroglu, S.; Korkmaz, G.; Bilgir, O.; Cagliyan, G.A.; Ozturk, H.B.A.; Serin, I.; Tiryaki, T.O.; Ozatli, D.; Korkmaz, S.; Ulas, T.; Eser, B.; Turgut, B.; Altuntas, F.
(2022)
Introduction/Background: The emergence of novel agents targeting the B-cell receptor pathway and BCL-2 has significantly changed the therapeutic landscape of CLL. We evaluated the safety and efficacy of single-agent ibrutinib ...